Clinical trial
Clinical Application of New Pheochromocytoma Markers: INSERM Pilot Study of the Specificity of Elevated Plasma EM66 Concentrations in Patients With Pheochromocytoma or Paraganglioma Compared to Patients With Essential Hypertension
NCT01022515 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Application of New Pheochromocytoma Markers: INSERM Pilot Study of the Specificity of Elevated Plasma EM66 Concentrations in Patients With Pheochromocytoma or Paraganglioma Compared to Patients With Essential Hypertension
- Lead sponsor
- University Hospital, Rouen
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2008
- Completion date
- April 13, 2022
- Enrollment
- 60 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.